Plasma Levels of Fluphenazine Decanoate
- 1 September 1988
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 153 (3) , 382-384
- https://doi.org/10.1192/bjp.153.3.382
Abstract
Depot neuroleptics are now commonly used for maintenance therapy of schizophrenia. Their physicochemical composition makes them ideal for such use because they are long-acting and show stable blood levels for prolonged periods. Their absorption from the site of injection may, however, be affected by local muscle factors. This paper describes three such factors in relation to fluphenazine decanoate: varying the site of injection; massage of the injection site; and effects of muscular exercise. Our results suggest that fluphenazine pharmacokinetics are not significantly affected by any of these factors.This publication has 7 references indexed in Scilit:
- Intramuscular or Intralipomatous Injections?New England Journal of Medicine, 1982
- Microscopic Evidence of Lymphogenic Absorption of Oil in Humans Receiving Neuroleptic Oily Depot Preparations IntramuscularlyActa Pharmacologica et Toxicologica, 1980
- Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.Published by Wiley ,1979
- Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazineActa Psychiatrica Scandinavica, 1978
- Radioimmunoassay for fluphenazine in human plasma.British Journal of Clinical Pharmacology, 1978
- Antiarrhythmic Effectiveness of Intramuscular Lidocaine: Influence of Different Injection SitesThe Journal of Clinical Pharmacology, 1974
- Plasma levels of lidocaine after intramuscular administrationThe American Journal of Cardiology, 1972